|
Alzheimers: FDA approval of dementia drug based on biomarkers?
MedPage Today Are biomarker-based endpoints adequate to prove efficacy in Alzheimer's drug trials? We asked two prominent experts: Eric Reiman, MD, executive director of the Banner Alzheimer's Institute in Phoenix, and Mary Sano, PhD, professor of psychiatry at the … |
Day: April 4, 2014
Iceland Foods raises £3.1m for Alzheimer’s Research UK – Huddersfield Examiner
Huddersfield Examiner |
Iceland Foods raises £3.1m for Alzheimer's Research UK
Huddersfield Examiner All the money raised is making a major contribution to dementia research, supporting studies into early-onset Alzheimer's, which can affect people under the age of 65. The research is focusing on improving diagnosis and understanding the risk factors … Iceland hands £3m to dementia cause |
A Dozen Things You Didn’t Know About Alzheimer’s – Huffington Post (blog)
WalesOnline |
A Dozen Things You Didn't Know About Alzheimer's
Huffington Post (blog) Alzheimer's is endlessly destructive. Most people think that Alzheimer's destroys people's ability to remember. But it's far worse than that. The dementia struggles of legendary UNC basketball coach Dean Smith, which have recently gone public … Ground-breaking global study into Alzheimer's disease to be led by Cardiff … Alzheimer's researchers may take age into account Researchers seek simple Alzheimer's test |
Twenty Years of Alzheimer’s Research May Have Focused on the Wrong Protein – Daily Beast
|
Twenty Years of Alzheimer's Research May Have Focused on the Wrong Protein
Daily Beast Five million Americans age 65 and older currently have Alzheimer's disease, according to advocacy organization the Alzheimer's Association. That number is expected to rise to 16 million in 2050. Because dementia results in the gradual loss of … |